Augmentin reconsidered
-
Relevant BNF section: 5.1.1.3
Abstract
The antibiotic co-amoxiclav (Augmentin - SmithKline Beecham) was first launched in the UK in 1981. When we reviewed it in 1982, we recommended it as second-line treatment for urinary infections and concluded that its place in other infections was unclear.1 Here we reassess the value of co-amoxiclav.
